Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software
JUNE 29, 2017 Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Poised to address diabetes on a global scale, the company expands its intellectual property protections in the United States and abroad. WALTHAM, MA — Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new...
Read More